| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $282.6M | $249.9M | $218.0M |
| YoY Revenue Growth % | +13.1% | +14.6% | — |
| Gross Profit | $224.8M | $195.1M | — |
| Gross Margin % | 79.5% | 78.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$23.6M | -$9.7M | -$28.8M |
| Operating Margin % | -8.3% | -3.9% | -13.2% |
| Net Income (GAAP) | -$32.9M | -$11.5M | -$29.4M |
| EBITDA (Normalized) | -$22.4M | -$8.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $14.6M | $30.2M | -$3.0M |
| Capital Expenditures (CapEx) | $1.5M | $1.4M | — |
| Free Cash Flow (FCF) | $13.2M | $28.7M | -$3.0M |
| FCF Margin % | 4.7% | 11.5% | -1.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $72.4M | $63.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $23.3M | $27.5M | — |